Facebook-f Twitter Envelope Instagram

Cancer Patients Alliance
is a 501(c)(3) non-profit.

All DONATIONS are tax-deductible.

Make an impact today!  

DONATE
Previous slide
Next slide
You have likely found us either because you have pancreatic cancer, or care about someone who does. Our mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.
Click Here to Contact us
Pancreatic cancer is the 3rd leading cause of cancer-related death in the U.S. It is expected to become the 2nd leading cause of cancer-related death. We need to find the disease earlier!
Donate to Research
Our aim is to present impartial knowledge about pancreatic cancer whereby interested parties can access the range of existing treatment options, to aid patient/doctor partnerships, and thus help medical teams optimize personal treatment strategies.
Click Here to Support the Cause
Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.
Click Here to make a tax-deductible Donation
Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.
Click Here to make a tax-deductible Donation
Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.
Click Here to make a tax-deductible Donation
Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.
Click Here to make a tax-deductible Donation
Together we can make a difference! Recently, a seasoned specialist told us that we had the highest social good to donation ratio that they had ever seen in any non-profit. We put all donations to serious use.
Click Here to find ways to Help or Donate
Pancreatic cancer is very aggressive. Fortunately together, so are we. There are many ways in which you can help the fight and make an impact for pancreatic cancer. Find the best way for you by clicking the link below.
Click Here to find ways to Help or Donate
Previous slide
Next slide

Author Archives: pancreatica

Mitazalimab receives orphan Status for pancreatic cancer

By pancreatica | Published June 1, 2023

Mitazalimab is a monoclonal antibody that targets CD40, a protein that is expressed on the surface of many types of cancer cells. CD40 signaling is thought to play a role in tumor growth and metastasis. Mitazalimab works by blocking CD40 signaling, which can lead to tumor cell death. The FDA has granted orphan drug designation […]

Posted in Pancreatic Cancer | Comments Off on Mitazalimab receives orphan Status for pancreatic cancer

Possible new treatments for pancreatic cancer

By pancreatica | Published June 1, 2023

Scientists have conducted a study, published in the journal Nature, that found pancreatic cancer cells rely on a molecule called uridine for energy when they are deprived of glucose. Uridine is a type of sugar that is not normally used by healthy cells. The researchers found that pancreatic cancer cells have a higher level of […]

Posted in Pancreatic Cancer Stories | Comments Off on Possible new treatments for pancreatic cancer

Early promise for mRNA vaccine that helps program the body to fight pancreatic cancer

By pancreatica | Published May 30, 2023

Studies have found an mRNA vaccine that programs the body to fight pancreatic cancer shows early promise. In a small clinical trial, half of the patients who received the vaccine did not have a recurrence of the tumor a year and a half later. The trial was published in the journal Nature on May 10, […]

Posted in Pancreatic Cancer Stories | Comments Off on Early promise for mRNA vaccine that helps program the body to fight pancreatic cancer

Abraxane and Gemcitabine for Advanced Pancreatic Cancer

By pancreatica | Published May 14, 2020

One of our favorite pancreatic cancer researchers, Dr. Daniel Von Hoff of TGen in Arizona – together with researchers from the Virginia G Piper Cancer Center – is reporting encouraging clinical trials results for those with advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) treated with a combination of Abraxane plus gemcitabine. This MPACT (Metastatic […]

Posted in Pancreatic Cancer Stories | Comments Off on Abraxane and Gemcitabine for Advanced Pancreatic Cancer

The Enzyme Returns: L-asparaginase encased in red blood cells for pancreatic cancer

By pancreatica | Published May 29, 2017

In late March 2017, the French biotech firm Erytech presented results of a IIb clinical trial of eryaspase (trade name: GRASPA) which is the enzyme l-asparaginase encapsulated in red blood cells as added to gemcitabine or FOLFIRINOX treatment regimens for patients with advanced pancreatic cancer (ductal adenocarcinoma of the pancreas), versus these standard therapies alone. […]

Posted in Medical Research, Pancreatic Cancer, Pancreatic Cancer Clinical Trials, Pancreatic Cancer Medical Treatment | Comments Off on The Enzyme Returns: L-asparaginase encased in red blood cells for pancreatic cancer

© 2023 Pancreatica. All rights reserved | Privacy Policy
312 Fountain Avenue, Pacific Grove, California 93950   |   Phone: (831) 658-0600   |   Fax: (831) 658-0518  |  participate@tofightcancer.com

Facebook-f Twitter Envelope Youtube